APA (7th ed.) Citation

T, D., RM, G., DJ, S., RF, M., CS, F., BP, F., . . . JA, M. (2004). Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: Results from Intergroup Trial N9741. Cancer, 101(10), 2170. https://doi.org/10.1002/cncr.20594

Chicago Style (17th ed.) Citation

T, Delaunoit, et al. "Mortality Associated with Daily Bolus 5-fluorouracil/leucovorin Administered in Combination with Either Irinotecan or Oxaliplatin: Results from Intergroup Trial N9741." Cancer 101, no. 10 (2004): 2170. https://doi.org/10.1002/cncr.20594.

MLA (9th ed.) Citation

T, Delaunoit, et al. "Mortality Associated with Daily Bolus 5-fluorouracil/leucovorin Administered in Combination with Either Irinotecan or Oxaliplatin: Results from Intergroup Trial N9741." Cancer, vol. 101, no. 10, 2004, p. 2170, https://doi.org/10.1002/cncr.20594.